Number of Shares
4,520.00
Current Holdings Value*
$1.62 Mil
% of Portfolio
3.12%
Total Estimate Gain
$-599,394.00
% of Total Estimate Gain
-4.48%

BNY Mellon U.S. Equity Fund's West Pharmaceutical Services Inc Holding Summary

As of 2024-02-29, BNY Mellon Strategic Funds, Inc. held 4,520.00 shares of West Pharmaceutical Services Inc(WST), totaling $1.62 Mil. This investment constitutes 3.12% of their stock portfolio, and BNY Mellon Strategic Funds, Inc. now holds 0.01% of the outstanding West Pharmaceutical Services Inc(WST) stock.

The initial trade took place in 2022Q2. And since then BNY Mellon U.S. Equity Fund has made 2 purchases of WST, at an average price of $336.82, for a total of 39,700.00 shares. In addition, there have been 3 sales at an average price of $327.20 for 35,180.00 shares. Based on historical transaction data and WST's current price of $279.10, BNY Mellon U.S. Equity Fund's estimated gain on his WST holdings is $-599,394.00, reflecting a -4.48% gain to date.

BNY Mellon U.S. Equity Fund WST ($279.10) Holding Chart

BNY Mellon U.S. Equity Fund WST ($279.10) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1